CUSIP: 03237H901
What is CUSIP 03237H901?
CUSIP 03237H901 identifies 03237H901 - AMYLYX PHARMACEUTICALS INC - CALL in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 03237H901:
As of 31 Dec 2025, 0 institutional investors reported holding shares of AMYLYX PHARMACEUTICALS INC - CALL.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $12.08 | 0 | |||
| 2025 Q3 | $13.59 | 0 | |||
| 2025 Q2 | $6.40 | 0 | |||
| 2025 Q1 | $3.52 | 0 | |||
| 2024 Q4 | $3.77 | 0 | |||
| 2024 Q3 | $3.19 | 0 | |||
| 2024 Q2 | $1.90 | 0 | |||
| 2024 Q1 | $2.84 | 0 | |||
| 2023 Q4 | $14.72 | 0 | |||
| 2023 Q3 | $18.31 | 0 | |||
| 2023 Q2 | $21.57 | 0 | |||
| 2023 Q1 | $29.34 | 0 | |||
| 2022 Q4 | $36.95 | 0 | |||
| 2022 Q3 | $28.15 | 0 | |||
| 2022 Q2 | $19.25 | 0 | |||
| 2022 Q1 | $13.92 | 0 |